Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

DSpace Repository

Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic situation

Author: Lagler, Heimo; Tobudic, Selma; Ramharter, Michael; Elandt, Katarzyna; Sperr, Wolfgang R.; Redlberger-Fritz, Monika; Popow-Kraupp, Theresia; Jaeger, Ulrich; Zielinski, Christoph C.; Burgmann, Heinz
Tübinger Autor(en):
Ramharter, Michael
Published in: Vaccine (2012), Bd. 30, H. 48, S. 6864-6870
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.vaccine.2012.09.005
ISSN: 0264-410X
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)